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Progressive muscular dystrophy is a  disease characterized by degeneration, 
weakness, and  atrophy of various groups of voluntary muscles, notably those 
of the lower extremities, pelvis, and shoulder girdles.  Several cfinical varieties 
have been described, based on the age of onset and location of the  affected 
muscles.  It is becoming increasingly clear, however, that  no sharp division 
can be made among many of the clinical types, and that  some fundamental 
defect common to the various syndromes may be responsible for the continuity 
and  sequence  of  phenomena  observed  in  this  group  of  muscular  disorders. 
Although  isolated  cases are  observed frequently, there  is  excellent evidence 
that the disease is hereditary and familial.  Males are more frequently affected 
than females, and in a  ratio of about 6:1.  In the male the disease also tends 
to be of greater severity and more rapidly progressive.  In females the disease 
may progress with only slight symptoms, and in  some  cases might pass un- 
noticed were it not for the occurrence of the syndrome in other members of 
the family. 
Notwithstanding the fact that progressive muscular dystrophy has engaged 
the attention  of the clinician,  the pathologist, and  the neurologist since the 
original description of this syndrome in the middle of the Nineteenth Century, 
biochemists and  physiologists,  for the  most  part,  had  failed  to  exhibit any 
sustained interest in this disorder until the work of Levene and Kristeller (1) 
in  1909.  These  workers  showed  that the  feeding  of protein  resulted in an 
an  excessive excretion of creatine in patients with progressive muscular dys- 
trophy.  Subsequently, many studies have revealed that marked derangement 
in  the  metabolism  of  creatine  exists  in  this  disease,  and  that  endogenous 
creatine, formed from protein and amino acids, i~ not retained nearly so effec- 
tively as  in  the normal subject  (2).  When  creatine is  ingested by patients 
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with progressive muscular dystrophy, much of it may be excreted in the urine, 
the amount retained depending to some extent on the severity of the disease. 
This  observation has  given  rise  to  the  concept  that  there  is  in  progressive 
muscular dystrophy a  "diabetic-like state" with respect to the ability of the 
patient  to  retain  either ingested creatine, or creatine which  is formed endog- 
enously from proteins and amino acids.  Whether or not this is a true concept, 
the recognition of the biochemical aberration in creatine metabolism is perhaps 
the only truly significant contribution  to have been made toward an under- 
standing of the essential nature of this disease within the last thirty years. 
Considerable  speculation  has  arisen  in  recent  years  over  the  significance 
which may be attached to the aberrant metabolism of creatine in diseases of 
muscle, with particular  reference to progressive muscular dystrophy.  There 
has been much controversy over factors which influence the excretion of this 
substance, not only in patients with diseased muscles, but in normal subjects 
as well.  An examination of the results of these studies reveals that in many 
instances little or no dietary control was exercised, while in others almost no 
cognizance was  taken  of the  factor of variation  in  physiological creatinuria 
with age and sex. 
The development of methods of greater specificity for the determination of 
creatine  and  creatinine  in  biological  material,  and  recent  studies  in  which 
isotopes of nitrogen  and  hydrogen  have been  employed, have given us new 
and  important  information  on  the  origin  and  metabolism  of  creatine  and 
creatinine.  As a  consequence,  many of the early statements concerning  the 
metabolism of creatine  and  creatinine  in  diseases  of muscle  need  to  be re- 
valuated, and  in  some instances rejected  entirely. 
In fine with the appearance of this information, it was decided to perform 
anew certain studies on the excretion of these substances, both in normal sub- 
jects and in patients with diseases of muscle, and to secure additional data on 
some of the many factors which are known to influence this process. 
Studies on the excretion of creatine in patients with progressive muscular dystrophy 
have been made by numerous investigators.  In general the level of creatine excretion 
has been found to be roughly proportional to the degree of severity of the disease, and 
is, therefore, of importance in clinical appraisal and prognosis.  Increased excretion 
of creatine in the urine, however, is by no means confined to diseases of muscle, but is 
observed in a variety of physiological  conditions,  e.g. starvation (3, 4), carbohydrate 
privation (5), acidosis (6), and as a result of feeding diets high in protein (7, 8).  In- 
creased  excretion  of creatine is also observed in a number of entirely unrelated dis- 
eases, notably malignancies,  fever, diphtheria, thyroid disease, and parathyroid dis- 
ease (9).  In children, utilization of data on the excretion of creatine as a guide to the 
state of progression of muscle disease is difficult, owing to the excretion, under physi- 
ological conditions,  of considerable quantities of creafine. 
Of equal importance with theincreased excretion of creatine in progressive muscular 
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creatinine formation and excretion with the integrity of muscle processes, the urinary 
concentration of this material may, in certain cases, give a more reliable indication of 
the severity of the disease than the level of urinary creatine.  Moreover, the relatively 
great constancy in the excretion of creatinine, even under widely differing conditions 
of diet and health of the subject, permits the attachment of greater significance to 
small changes in the urinary concentration of this material than is  the case  with 
creatine, which may show wide fluctuations from day to day. 
The constancy with which creatinine is excreted, and its apparently complete lack 
of relation to the total metabolism of protein were cited by Folin (15) as evidence that 
creatinine is the product of a special type of metabolism which proceeds at a uniform 
velocity in all living cells of the body independent of the many events which influence 
the excretion of creatine.  Later Shaffer  (10) suggested that creatinine is not derived 
from all tissues, but that it arises as a result of a special process  of tissue catabolism 
taking place "largely, if not wholly in the muscles."  Upon this hypothesis was based 
the belief that the amount of creatinine excreted in the urine "bears a direct relation 
to the potential efficiency of the muscles and is a reliable index of the muscular de- 
velopment of an individual."  The belief, originally stated by Folin, that creatinine 
formation represents a  type of endogenous metabolism distinct from the exogenous 
metabolism of food protein is no longer tenable, as a result of the studies performed 
by Schoenheimer and his associates (11) with isotopic nitrogen.  The constant daily 
excretion of creatinine, in contrast to the highly inconstant  excretion of other nitrog- 
enous constituents of the urine, however, indicates that the  formation of  creatinine 
is an orderly and well regulated process,  the biological significance of which is not 
entirely apparent.  That it arises directly from creatine is abundantly clear from the 
isotope experiments of Bloch, Schoenheimer, and Rittenberg (12).  Moreover, it is 
also clear from the results obtained by numerous investigators that its origin from 
creatine is somehow associated with the utilization  of creatine by the muscles, and that 
the quantity of creatinine in the urine is a fairly adequate measure of the extent to 
which creatine is being metabolized. 
Materials  and Methods 
Data reported  in this communication have been obtained  from Six male children with 
progressive muscular dystrophy,  and from five normal male children, within the same age 
group, in whom no evidence of muscle disease could be elicited.  The subjects reported herein 
were selected from a larger group of 40 patients with progressive muscular dystrophy as being 
most representative of the disease in its principal stages, from moderate to severe involvement. 
An account of certain clinical studies performed on the larger group of patients has appeared 
in an earlier communication  (13).  A preliminary  statement regarding the nature of the 
specific changes in the muscles of some of the cases reported in this paper, as revealed by ultra- 
violet light photomicrography, has also appeared  (14).  Throughout  the period of observa- 
tion, patients and normal subjects were maintained  on a diet of constant composition, high in 
protein and moderately low in carbohydrate and fat.  By careful control of the diet, fluctua- 
tions in the excretion of creatine due to this factor were held to a minimum.  During the 
control period, and for several days after initiation of a given experiment, urine specimens 
were collected quantitatively over periods of 24 hours.  These were kept at 5°C. until ready 
for analysis, a period of time which rarely exceeded 48 hours.  When the trend of the analyti- 
cal data was established, the interval of collection was lengthened and the urine stored at low 
temperature  until the collection for a given period was complete.  Determinations  of pre- 426  PROGRESSIVE  MUSCULAR  DYSTROPHY 
formed creatine and total creatinine were made by the method of Folin (15), with certain 
modifications of the classical method in order to adapt it to the photoelectric cell colorimeter. 
The determination of glycocyamine  was carried out by the technique of Dubnoit and Borsook 
(16), with slight modifications. 
EXPERIM~ENTAL 
In this study, the creatine excretion of a series of normal preadolescent males 
was found to be approximately one-half to two-thirds that observed in a group 
of  children  with  progressive  muscular  dystrophy.  Although  stabilization 
of the excretion of creatine was enhanced by feeding a  diet of  constant com- 
position  from day  to  day,  there  was,  nevertheless,  considerable  fluctuation 
in creatine excretion for a variable interval following the ingestion of food.  A 
certain daily rhythm in the excretion of creatine in both the normal children 
and the children with muscular dystrophy was observed, with its peak occurring 
in the morning and its lowest point occurring during the night.  This so called 
rhythm of excretion of creatine in normal children was first recorded by Powis 
and  Raper  (17)  in  1916.  As a  consequence  of the  physiological creatinuria 
and its marked fluctuation in the subjects under study, it was considered unwise 
to attempt an evaluation of any but the major changes in creatine excretion 
observed during the study of each case. 
Relation between the Level of Excretion of Urinary Creatinine and Residual Mass 
of the Muscles  in  Progressive Muscular  Dystrophy 
The marked decrease in  the  output  of creatinine  observed consistently in 
patients with progressive muscular dystrophy has been attributed  frequently 
to the reduction in the total mass and efficiency of the muscles which occurs 
in the disease (2).  In Table I  are listed .the results of an attempt which was 
made to give quantitative expression to the degree of loss of mass and efficiency 
in  the  muscles in  this  disease,  by a  consideration  of the  ratio  of creatinine 
excretion  in  patients  with progressive muscular  dystrophy  to  that  observed 
in a series of normal subjects within a comparable ~,ge group.  The calculations 
were made on the assumption  that in  the normal subject 40 per cent of the 
body weight is muscle.  Normal creafinine values used in  these  calculations 
were obtained from the five control subjects.  The values, expressed as milli- 
grams of creatinine excreted  per kilogram of body weight in  24 hours, agree 
closely with  those  given by other  workers  for normal male children  in  this 
age group (9).  On the basis of the results given in Table I, it can be seen that 
in advanced progressive muscular dystrophy tl~e mass of functioning muscle, 
as inferred from the creatinine findings, may be as little as 17 per cent of the 
body weight, or less than haft of that of normal subjects.  That the concentra- 
tion of creatinine in the urine bears more than a casual relationship to the mass 
and efficiency of the muscles in children with progressive muscular dystrophy 
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values recorded in Table I  are typical of those found for a  larger number of 
patients exhibiting this disease in whom studies have been less complete.  In all 
cases in which the creatinine excretion has been carefully studied,  there has 
been found a  marked correlation between the amount of muscle as per cent 
of body weight, inferred from a consideration of the data on creatinine excretion, 
and the degree of physical performance of the patients, in so far as  such per- 
formance  could  be  appraised  in a  quantitative  fashion.  In  our experience 
the  calculation of the  muscle mass  on  the  basis  of  the  creatinine  excretion 
has been a  fairly reliable index of the extent of involvement of  the  muscu- 
lar system in  patients with  this disease as determined clinically.  Moreover, 
by performing this type of calculation at  frequent intervals on a  given sub- 
TABLE  I 
Calculation of Residual Muscle Mass of Patients with Progressive Muscular Dystrophy from 
Data on Creatinine Excretion 
Case No. 
Average values on 5 nor- 
mal subjects ........... 
Patients with progressive 
muscular dystrophy 
1 
2 
3 
4 
5 
6 
Excretion of creatinine 
Mg./kg. body 
weight/24 hrs. 
21.6 
9.5 
10.0 
10.3 
11.6 
13.1 
18.7 
Muscle mass 
Per cent of body weight 
Estimated at 40 
per cent 
17.6 
18.5 
19.0 
21.5 
24.2 
34.6 
Degree of clinical 
involvement 
None 
++++ 
+++ 
+++ 
++ 
++ 
+ 
ject with progressive muscular  dystrophy, a  fairly quantitative  appraisal of 
the clinical condition of the patient and the rate of progression of the disease 
can be ascertained. 
Methyl  Group Reserves in  Progressive Muscular Dystrophy 
Following the elucidation by Borsook and Dubnoff (18), and du Vigneaud 
and associates  (19), of the r61e of methionine in the synthesis of creatine and 
creatinine,  speculation  arose  in  this  laboratory  over  the  possibility  that  a 
deprivation of methyl groups may occur in certain diseases characterized by 
excessive creatinuria.  In progressive muscular dystrophy, for example, does 
there  develop a  state of methyl group  deprivation as  a  result of the exces- 
sive  and  prolonged creatinuria  which is characteristic of  this  disease?  The 
idea  that an  exhaustion of methyl groups may occur when the  demand for 428  PROGRESSIVE  MUSCULAR DYSTROPI:IY 
methyl groups is artificially raised by feeding an excess  of methyl acceptor is 
implied in the results obtained by du Vigneaud and associates (20),  who found 
that growth in rats,  which was inhibited  by feeding of excess  glycocyamine, 
was resumed following addition to the diet of the methyl donors, choline and 
methionine.  It has also been reported that the addition of glycocyamine to an 
otherwise adequate diet resulted in the production of fatty livers and in the 
reduction of liver choline to values below that observed when animals were 
TABLE II 
Total  Quantities  of "Methyl"  Excreted  as  Creatine  and  Creatlnine  in  Normal Subjects  and 
Palients with Progressive Muscular Dystrophy 
Normal subjects 
1 
2 
3 
4 
5 
Age 
yrs. 
I0 
11 
I1 
9 
10 
Average ...................... 
Patients with pro- 
gressive muscu- 
lar dystrophy 
1 
2 
3 
'4 
5 
8 
7 
4 
8 
11 
"CHd' output as 
Creatine  [  Creatinine 
Mg./kg. body  weight/24 hrs. 
To~l 
2.10  2.51 
1.29  2.61 
0.74  3.01 
1.87  3.01 
1.22  3.22 
1.44  2.87 
2.27  1.37 
2.91  1.54 
2.22  2.49 
2.55  1.33 
3.06  1.26 
2.60  1.60 
4.61 
3.90 
3.95 
4.88 
4.44 
4.39 
3.64 
4.46 
4.71 
3.88 
4.32 
'Average .......................  4.20 
placed on a  choline-free diet  (21).  Handler and Dann  (22),  moreover, have 
recently reported that inhibition of growth produced by an excessive intake of 
nicotinamide was prevented by the administration of methionine or by choline 
and homocystine.  Although alternative hypotheses must be entertained,  the 
results of these experiments indicate that in the presence of an excess of sub- 
stances which act as methyl acceptors, a deficiency of methyl groups may occur, 
and that this deprivation may be prevented by an adequate intake of methyl- 
ating  agents  such as methionine and  choline.  In order  to learn whether de- 
ficiency of methyl groups occurs in progressive muscular dystrophy, the total 
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with that of control subjects without evidence of muscle disease.  The results 
are given in Table II.  It will beseen at a glance that no evidence of exhaustion 
of methyl group reserves can be obtained from a consideration of the levels of 
urinary excretion of creatine and creatinine.  It win be observed that any loss 
in  methyl groups,  greater  than  that  seen in  normal  children, occurring as a 
result of excessive creatine output, is fully compensated for by a  diminution 
in the output of creatinine in the diseased patients.  It may be observed also 
that  there is a  surprising  agreement between the total quantity of "methyl" 
excreted by the group of normal subjects and that excreted by patients with 
progressive muscular dystrophy.  These data suggest that there is no increase 
in the output of total creatine compounds in progressive muscular dystrophy 
over that of normal subjects with a  comparable age range, and that the differ- 
ence in children between the normal subjects and the patients  with dystrophy 
resides rather in the partition of the substance excreted in the urine.  In view 
of the fact that creatinine has been shown by means of isotopes to be derived 
from creatine, it would appear from a  consideration of these results, that in 
progressive muscular dystrophy the excessive creatinuria does not arise as a re- 
sult of an increase in the synthesis of creatine, but rather as a result of the in- 
complete metabolism of  this  material  in  the  muscle with  a  consequent de- 
crease in the amount converted to creatinine. 
Effects  of the  Administration  of  Certain  Hormones  on  Creatinuria 
in  Progressive  Muscular  Dystrophy 
During a  period of 3 years in  which  the problem of progressive muscular 
dystrophy has been under study at the Rockefeller Hospital, only five females 
with unequivocal signs of progressive muscular dystrophy have been encount- 
ered in a  group of 46 patients who have been admitted to the clinic with this 
disease.  Moreover, as pointed out previously, the disease generally runs a more 
acute course in male children than in the occasional female child in whom the 
disease is encountered.  These observations tend to lead one to the hypothesis 
that the essential aberration in progressive muscular dystrophy is one connected 
closely with the biological phenomenon of maleness on the one hand, and per- 
haps with those systems concerned with growth and development on the other. 
Certain of these phenomena are mediated through the hormones of the anterior 
pituitary,  the  adrenal  cortex,  and  the  gonads.  It  was  believed,  therefore, 
that an investigation of the effects of certain of these agents on the metabolism 
and clinical course of patients with this disease should be carried out. 
Several papers have appeared recently, including a preliminary report from 
this laboratory, dealing with the effect of the steroid  hormones, particularly 
testosterone propionate, on the growth and development of the muscular system, 
and more specifically on the metabolism of creatine (23-29).  Since creatinuria 
is considered to be the most consistent abnormality in the metabolism of pa- 430  PROGRESSIVE  MUSCULAR DYSTROPHY 
tients with progressive muscular dystrophy, any agent which may affect the ex- 
cretion of this substance seemed to us to possess particular interest in  connec- 
tion with a  study of this syndrome.  Accordingly a  study has been made  of 
the effect of certain of the steroid hormones, including testosterone propionate 
and  methyl  testosterone,  I  on  the  metabolism  of  creatine,  creatinine,  and 
glycocyamine in  a  group  of  male  children  with  progressive  muscular dys- 
trophy, and, for purposes of comparison, in a group of normal male children as 
controls.  The determination of glycocyamine was  included in  these studies 
because of its  known  r61e  in  the  biological  synthesis  of  creatine, and  be- 
cause its excretion has been shown to be altered in  patients with progressive 
muscular  dystrophy (30).  Less  complete  studies were  also  carried  out  on 
the effects of  desoxycorticosterone acetate,  a  purified  preparation  of  cho- 
rionic  gonadotropin,  and  a  concentrate  containing  both  the  gonadotropic 
and  thyrotropic hormones of  the  hypophysis.  As  in  the  foregoing  studies 
on creatine excretion, patients and  control subjects were placed on diets  of 
constant composition and base lines obtained in each case for the excretion of 
creatine, creatinine, and glycocyamine.  After a  control period, during which 
the  excretion  of  these substances  was  found  to  be  constant,  the  hormone 
selected for study was  administered over a  period of time adequate  to  test 
its effect.  The hormone was then discontinued and determinations of creatine, 
creatinine, and  glycocyamine made until approximately  the former levels of 
excretion of these substances were reached. 
Effects of the Administration  of Testosterone Propionate.--Muscular  develop- 
ment is promoted by the male sex hormones in animals (31) and in man (32- 
34).  Various tests, objective in character, have shown a  measurable increase 
in muscular performance in human  subjects,  following the administration of 
male  hormone.  The  male  hormone  has  been  shown  to  foster ~he  deposi- 
tion of creatine in muscle, resulting in added weight and strength of this or- 
gan  system  (27).  After  a  suitable  control  period,  testosterone  propionate 
was administered  intramuscularly to male children with progressive muscular 
dystrophy in doses of 20 mg, a  day  over a  period of 10 to 14 days.  In five 
patients  the administration of the hormone was  continued in doses of 10 to 
20 mg., 2 to 3 times weekly, for periods of 2 to 3 months with determinations 
of creatine and  creatinine performed at  regular, but less  frequent intervals. 
Certain  differences between  the  effect of testosterone propionate on  the  ex- 
cretion of creatine and glycocyamine in normal  subjects and in patients with 
progressive muscular dystrophy were immediately  apparent.  In the normal 
controls there was a marked drop in the excretion of creatine within 72 hours 
following  the  administration  of  testosterone propionate,  which  persisted  as 
1 We are greatly indebted to Dr. L. A. Pirk, of Roche-Organon, Inc., Nutley, New Jersey, 
for  the  testosterone  propionate  (neo-hombreol),  methyl  testosterone  (neo-hombreol  M), 
ambinon, pregnyl, and desoxycorticosterone acetate (doca)  used in these studies. C. L. HOAGLAND,  H. GILDER,  AND R. E. SHANK  431 
long as the hormone was administered.  Immediately following the withdrawal 
of the hormone there ensued a  marked crcatinuria for several days,  at which 
time the  creatine  excretion  reached a  level greater than  that  of the  control 
period.  Results on  a  typical normal subject are given in Fig. 1.  In patients 
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FIG. 1.  Curves showing the influence of testosterone propionate on the urinary excretion 
of creatine, creatinine, and glycocyamine  in a normal child of 8 years. 
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FIG. 2.  Curves showing the influence of testosterone propionate on the urinary excretion 
of creatine, creatinkne, and glycocya.mine  in a child with moderately advanced progressive 
muscular dystrophy. 
with  progressive muscular dystrophy,  no  significant  change  occurred  in  the 
excretion of  creatine during  the interval in which  the hormone was adminis- 
tered.  However, as in the normal subjects, a marked increase in the excretion 
of creatine was observed for several days following the withdrawal of testoster- 
one  propionate.  Data on a typical case with progressive muscular dystrophy 
are  represented  in graphic form in Fig. 2.  No significant change in the excre- 
tion of creatinine was apparent either  in patients  with progressive muscular 
dystrophy or in normal subjects following the administration of testosterone pro- 432  PROGRESSIVE  MUSCULAR  DYSTROPHY 
pionate.  Clinical response to the hormone, manifested by marked changes in 
the secondary sex characters, was manifested in each case receiving testosterone 
propionate within 10 days to 2 weeks.  These changes, which were evidenced in 
lowered pitch of  the voice, acceleration of  the growth of pubic and axillary 
hair,  and  enlargement  of  the  genitalia,  persisted  in  some  cases  for several 
weeks following withdrawal of the hormone.  Certain  psychological changes 
similar  to  those  which  occur  normally  at  the  onset  of  adolescence,  were 
also  observed.  No  final  statement  regarding  the  effect  of  testosterone 
propionate  on  the  clinical  course  of the  disease  can  be made  at  this  time. 
Although  marked  clinical improvement in  coordination and  strength  of  the 
muscles followed the administration  of the hormone in one case of early pro- 
gressive muscular dystrophy, it is not certain at this time that the  effect can 
be directly attributed to treatment with testosterone propionate.  Certainly no 
dramatic or unequivocal signs  of improvement were observed in  other cases 
receiving the hormone.  It should be remarked in  this  connection, however, 
that the rate of progression of the disease is extremely variable  from  case  to 
case, and adequate controls are so difficult to set up that many cases will have 
to  be studied before it can be stated with certainty whether or not improve- 
ment is obtained. 
Effects  of the  Administration  of Methyl  Testosterone.--Methyl  testosterone 
is said to be a completely potent androgen and to be similar in its clinical effects 
to  testosterone propionate.  The methyl derivative differs from testosterone 
propionate,  however,  in  that  it  can  be  administered  by  mouth.  It  differs 
from testosterone propionate, also in that it has been shown to produce marked 
creatinurla (35).  Creatine storage, however, is said to occur with this agent, 
and the accompanying creatinuria has been explained as being due to an accel- 
erated synthesis of creatine (36). 
Three patients with progressive muscular dystrophy were given 20 mg.  of 
methyl testosterone orally for a period of 10 days, and an analysis of the urine 
for creatine, creatinine, and glycocyamine performed as before.  The  results 
Obtained  with  a  typical  patient  are  given  in  Fig.  3.  Since  the  effects of 
methyl testosterone on the excretion of creatine in normal children have been 
thoroughly explored by others (35, 36), only one normal male child was deemgd 
necessary as a  control subject.  In  contradistinction to  the effects observed 
with testosterone propionate, however, there was a marked increase in creatine 
excretion in  the normal subject immediately following the administration  of 
methyl testosterone, which was maintained as long as the hormone was con- 
tinued.  A marked increase in urinary glycocyamine likewise occurred.  Upon 
withdrawal of methyl testosterone, no further increase occurred in the output 
of either creatine or glycocyamine.  On the contrary, there was a rapid drop in 
the  excretion  of  these  substances  until  the  previous  levels  of  output  were 
attained.  No  significant  alteration  in  the  excretion  of  creatinine  occurred C. L. HOAGLAND~  H. GILDER, AND  R. E. SIIANK  433 
in either the normal control subject or in the patients with progressive muscular 
dystrophy.  Various  explanations  of  the  effect  of  methyl  testosterone  in 
provoking  creatinuria  have  been  offered.  Most  workers  assume  that  crea- 
tinuria  following the administration  of this substance is due to an actual in- 
crease in the rate of creatine synthesis, with consequent excretion of the excess 
creatine  (36).  The marked increase  in  excretion  of glycocyamine, a  known 
biological intermediary in the synthesis of creatine, is in keeping with this idea. 
In  this  connection  it  is  interesting  to  speculate  on  the  possibility  that  the 
creatinuria  following  the  administration  of  methyl  testosterone  results  pri- 
marily from an increase in  the  rate of formation of glycocyamine, and  that 
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FIG. 3.  Curves showing the influence of methyl testosterone on the urinary excretion of 
creatine,  creatinine, and  glycocyamine in  a  child with  moderately advanced progressive 
muscular dystrophy. 
methylation of the glycocyamine occurs secondarily, resulting in an excessive 
output of creatine. 
The  phenomenon  of  creatinuria  following  the  administration  of  methyl 
testosterone has been cited by Tager (37)  as evidence that the hormone acts 
in large doses as a methylafing substance.  The idea that methyl testosterone 
provokes  creatinuria  in  this  manner  may  be  attractive  but,  unfortunately, 
is not supported by the facts.  Indeed,  there is considerable evidence to the 
contrary inherent  in Tager's own data.  A  comparison between  the amount 
of "methyl" supplied in  the form of methyl testosterone and the amount of 
methyl appearing in the excess urinary creatine in his cases, shows that on the 
consideration of mass alone, the hormone could account at the most for only 
a  small part of the total methyl excreted, assuming that all of the "methyl" 
contained in the hormone were available for methylation. 
The Effects of Concentrates  of Hormones of the ttypophysis  on the Excretion 
of  Creatine  and  Creatinine  in  Progressive  Muscular  Dystrophy.--Because  of 434  PROGRESSIVE  MUSCULAR  DYSTROPHY 
the current concept that  the  formation of creatinine is intimately bound up 
with the normal metabolism of creatine, it was considered logical to test the 
effects of those hormones which are believed to accelerate the production of 
creatine and promote the formation of creatinine in animals  and  in  normal 
human subjects.  According to some workers the excretion of urinary creatinine 
is increased in animals and man by the growth hormone of the anterior pituitary 
(38),  the  gonadotropic hormone of  the  hypophysis (39), and  by certain  ex- 
tracts of the anterior pituitary  (40).  Two hormone concentrates were made 
available  for this study.  The  first, a  concentrate of  the  gonadotropic  and 
thyrotropic  principles of the hypophysis  (ambinonl), containing 50 rat units 
of gonadotropic principle and 200 guinea pig units of the thyrotropic principle 
per cc., was administered in doses of 1 cc. three times weekly for 20 and 40 days, 
respectively, to two male children with progressive muscular  dystrophy.  No 
detectable changes in the excretion of creatine or creatinine were observed in 
either case.  Moreover, no detectable change in the clinical status of the pa- 
tients was evident.  The second preparation, a  chorionic gonadotropic concen- 
trate with pituitary-like properties (pregnylt), containing 500 I.U. per cc., was 
administered intramuscularly to another patient with muscular dystrophy, in 
doses of 1 cc. 2 times a week for 1 month.  No changes in the levels of excre- 
tion of creatine or creatinine were observed, and  no  changes  in  the  clinical 
status of the patient were detected. 
The  Effect  of Desoxycorticosterone  Acetate  on the  Excretion  of Creatine  and 
Creatinine.--Two  patients with moderately severe progressive muscular dys- 
trophy were selected for study, and placed on 5  and  10  rag.  respectively of 
desoxycorticosterone  acetate  (doca0,  by  intramuscular  injection,  3  times 
weekly.  No  changes  in  the  levels of excretion of creatine or creatinine,  or 
in the clinical status of the patients were detected after 40 days of this regimen. 
DISCUSSION 
Although much speculation  has  accompanied  the  published  results  of in- 
vestigation on progressive muscular dystrophy, little has been added  to our 
concept of the  essential  nature  of this  syndrome since  the  discovery of an 
aberrant metabolism of creatine in  this disease by Levene and KristeUer, in 
1909  (1).  After  thirty years  of investigation,  we  must  continue  to  regard 
creatinurla as the most striking manifestation exhibited by patients with this 
disease.  Evidence has  been presented which  leads  us  to  believe, however, 
that the essential defect is not to be found in the mechanisms which control 
the synthesis of creatine or in the mechanisms responsible for transport of this 
substance, but rather in those systems which in normal muscle are linked with 
the production of creatinine.  Although creatinuria may arise in many diseases, 
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of muscle does there occur at the same time a marked diminution in the urinary 
excretion of  creatinine.  Of  the  diseases  of muscle  which  are characterized 
by creatinuria and diminution in excretion of creatinine, progressive muscular 
dystrophy is the most outstanding example.  Notwithstanding the invariable 
association of diminution of creatinine excretion with this syndrome, however, 
we have no evidence that the disease arises as a  result of a defect in the syn- 
thesis of this substance.  It is perhaps best to regard the phenomenon of di- 
minished creatinine excretion as evidence of a  defect which is far more subtle, 
and which  results among other things in the lessened production of this sub- 
stance.  In fact there has been no adequate evidence presented thus far to show 
that genuine qualitative changes occur in  the metabolism of muscle in  this 
disease.  Until such  changes  are  demonstrated  the  disease  will continue  to 
escape  classification  with  the  rare  inborn  diseases  of  metabolism,  e.g.  al- 
kaptonuria, cystinuria, etc., in which changes of a qualitative character in the 
metabolism are evident.  It is even possible  that the inherent defect in pro- 
gressive muscular dystrophy  lies entirely outside  the musculature, and  that 
the chief symptoms of the disease are expressed in degenerative changes in the 
muscles. 
Of the factors which are believed to influence the synthesis and utilization 
of creatine, the hormones of the adrenal cortex, the gonads, and the anterior 
pituitary are the best known.  It was in an effort to learn something of the 
extent to which these factors operate in the production of creatinuria  in pro- 
gressive muscular dystrophy that the foregoing study was initiated. 
In  general,  it may be said  that  the effects of testosterone propionate and 
methyl  testosteron~e  in  patients  with  progressive  muscular  dystrophy,  are 
qualitatively like  those in  normal male  children of comparable ages,  except 
that the storage of creatine in the normal child receiving testosterone propionate 
is  more readily demonstrated  than  in  patients  with marked muscle disease. 
This may be explained in part by a diminution in the capacity of the muscle in 
progressive muscular dystrophy to store creatine, and also by the fact that in 
the presence of an excessive creatinuria the storage of creatine, in so far as it 
is reflected by a  diminution in output, is harder to demonstrate.  The possi- 
bility must be kept in mind, however, that the male hormones may be unable 
to  influence  the  storage  and  utilization  of  creatine  to  the  same  extent in 
patients with muscle disease as in normal subjects, owing to a possible defect 
inherent  in  the  muscles  per  se. 
If creatine retention, which  occurred as  a  result of the  administration of 
testosterone propionate,  is  to  be regarded as a  true storage phenomenon, it 
would suggest that  in progressive muscular dystrophy the capacity to store 
creatine is not irreversibly altered.  It seemed, therefore, that we were justi- 
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whether  improvement  in  muscle  function  could  be  accomplished  thereby. 
In this connection, results of the present study have been disappointing.  In 
one case only did it appear that favorable clinical results had  been attained. 
In this instance the disease was in its earliest stages, and although there  was 
unequivocal evidence of marked improvement in muscle function and  in the 
clinical status of the patient following the administration of testosterone pro- 
pionate, it cannot be ascribed with certainty to a  specific effect of  the male 
hormone.  It should be pointe~ out that in p.rogressive muscular  dystrophy 
effective controls are nearly impossible,  because of the  extreme variation in 
severity and rate of progression of the disease from case to case.  Therefore, 
the effect of any agent on the rate of progression of the disease, unless truly 
dramatic,  would be difficult to evaluate clinically. 
SITMMARY 
The diminished excretion of creatinine in progressive muscular dystrophy is 
a more striking and specific phenomenon than the excess excretion of creatine, 
marked  though  this  is.  While  creatinuria  is  invariably  encountered  in  all 
cases of long-standing dystrophy, the extent to which the excretion of creatinine 
is decreased provides a  more reliable indication of the severity of the disease 
since an excess output of creatine may occur physiologically in normal human 
subjects  and  in  many  pathological  conditions  not  known  to be associated 
with muscle disease. 
In  progressive muscular  dystrophy the  residual  muscle  mass,  as  inferred 
from the excretion of creatinine, provides a  useful index of the state of the 
disease at any given time. 
Although there is excessive creatinuria in progressive muscular dystrophy, 
there is no evidence that a  deprivation of methyl stores occurs through a loss 
of urinary creatine.  The loss of methyl groups contained in the excess creatine 
is,  under ordinary conditions of diet,  almost  exactly compensated for by ~, 
drop in the excretion of methyl groups in the urinary creatinine. 
Testosterone  propionate,  administered  over variable  periods  of  time,  re- 
sulted in the retention of creatine both in normal male children and  in male 
children with progressive muscular dystrophy, as shown in the normal subjects 
by a  diminution in creatine output, and in both by an excess creatinuria for 
variable periods of time following withdrawal of the hormone.  An  increase 
in the excretion of creatine in progressive muscular dystrophy occurred follow- 
ing the administration of methyl testosterone.  Neither testosterone propionate 
nor methyl testosterone appeared to effect any consistent change in the output 
of urinary creatinine. 
No effects on the excretion of creatine and creatinine were observed following 
the prolonged administration of a concentrate of gonadotropic and thyrotropic C. L. HOAGLAND,  H. GILDER~  AND  R. E. SHANK  437 
principles of the hypophysis, or from the administration of desoxycorticoster- 
one acetate to patients with progressive muscular dystrophy. 
Except in one case, in which marked improvement was observed following the 
administration of testosterone propionate, no effects on the clinical course of 
the patients with progressive muscular dystrophy were observed as a  result 
of treatment by any of the various hormones employed in this study. 
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